Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $15.38 in the prior trading day, Avadel Pharmaceuticals plc (NASDAQ: AVDL) closed at $15.59, up 1.37%. In other words, the price has increased by $1.37 from its previous closing price. On the day, 1.33 million shares were traded. AVDL stock price reached its highest trading level at $15.59 during the session, while it also had its lowest trading level at $15.0.
Ratios:
Our goal is to gain a better understanding of AVDL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.56 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 257.01. For the most recent quarter (mrq), Quick Ratio is recorded 2.38 and its Current Ratio is at 2.79. In the meantime, Its Debt-to-Equity ratio is 0.42 whereas as Long-Term Debt/Eq ratio is at 0.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on September 03, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 21 ’25 when Palczuk Linda bought 5,000 shares for $7.93 per share. The transaction valued at 39,640 led to the insider holds 67,900 shares of the business.
Thornton Peter J. bought 10,000 shares of AVDL for $80,450 on Jan 13 ’25. The Director now owns 104,055 shares after completing the transaction at $8.04 per share. On Jan 13 ’25, another insider, Ende Eric J, who serves as the Director of the company, bought 30,000 shares for $7.84 each. As a result, the insider paid 235,218 and bolstered with 208,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVDL now has a Market Capitalization of 1513751552 and an Enterprise Value of 1470248192. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.85 while its Price-to-Book (P/B) ratio in mrq is 16.63. Its current Enterprise Value per Revenue stands at 6.65 whereas that against EBITDA is 4129.911.
Stock Price History:
The Beta on a monthly basis for AVDL is 1.46, which has changed by 0.14212453 over the last 52 weeks, in comparison to a change of 0.1725707 over the same period for the S&P500. Over the past 52 weeks, AVDL has reached a high of $16.66, while it has fallen to a 52-week low of $6.38. The 50-Day Moving Average of the stock is 28.37%, while the 200-Day Moving Average is calculated to be 59.67%.
Shares Statistics:
The stock has traded on average 1.45M shares per day over the past 3-months and 1635570 shares per day over the last 10 days, according to various share statistics. A total of 96.78M shares are outstanding, with a floating share count of 88.92M. Insiders hold about 8.42% of the company’s shares, while institutions hold 80.85% stake in the company. Shares short for AVDL as of 1755216000 were 10122790 with a Short Ratio of 7.00, compared to 1752537600 on 12312691. Therefore, it implies a Short% of Shares Outstanding of 10122790 and a Short% of Float of 12.1700004.
